Alcon Inc(ALC-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low67.85
Day High69.13
Open:67.98
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
GlobeNewswire
Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs
Zacks Investment Research
How COO Is Riding Myopia and Fertility Trends Amid Execution Risks
How COO Is Riding Myopia and Fertility Trends Amid Execution Risks
Tipranks
Analysts Offer Insights on Healthcare Companies: Evommune, Inc. (EVMN), Immunome (IMNM) and Alcon (ALC)
Tipranks
Alcon (ALC) Gets a Buy from Citi
Tipranks
Analysts Have Conflicting Sentiments on These Healthcare Companies: Alcon (ALC) and Oruka Therapeutics (ORKA)
Tipranks
UBS Remains a Buy on Alcon (ALC)
Tipranks
Alcon Earnings Call Highlights Growth Amid Margin Strains
Tipranks
Analysts Offer Insights on Healthcare Companies: Alcon (ALC), Argenx Se (ARGX) and Definium Therapeutics (DFTX)
Tipranks
Alcon (ALC) Gets a Buy from RBC Capital
Tipranks
Analysts Conflicted on These Healthcare Names: ACADIA Pharmaceuticals (ACAD), Qiagen (QGEN) and Alcon (ALC)
Tipranks
Analysts Offer Insights on Healthcare Companies: Idexx Laboratories (IDXX) and Alcon (ALC)
Tipranks
Bank of America Securities Sticks to Their Sell Rating for Alcon (ALC)
Tipranks
Analysts Offer Insights on Healthcare Companies: Alcon (ALC), Senseonics Holdings (SENS) and Dianthus Therapeutics (DNTH)
Tipranks
Alcon Q1 2026 Sales Rise 10% as New Eye-Care Products Power Growth and $1.5 Billion Buyback
Motley Fool
Alcon (ALC) Q1 2026 Earnings Call Transcript
Zacks Investment Research
ISRG Stock Up as Q1 Earnings & Sales Beat Estimates on Procedure Growth
ISRG Stock Up as Q1 Earnings & Sales Beat Estimates on Procedure Growth
Tipranks
Wall Street Analysts Are Bullish on Top Healthcare Picks
Tipranks
Mizuho Securities Gives a Buy Rating to Alcon (ALC)
Tipranks
Analysts Have Conflicting Sentiments on These Healthcare Companies: Edwards Lifesciences (EW), Alcon (ALC) and Elanco Animal Health (ELAN)

Profile

Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.